Orthogonal Receptor-Ligand Selection via CPR Emulsion PCR
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for developing orthogonal GPCR-ligand pairs for DREADDs are limited by reliance on growth assays, lack of negative selection techniques, and difficulty in identifying specific compounds that do not affect neural receptors, hindering the production of new DREADDs and simultaneous modulation of neural interactions.
Innovation Solution
The implementation of Receptor Compartmentalized Partnered Replication (CPR) using a thermostable polymerase coupled to signal transduction pathways, allowing for the selective amplification of receptor-ligand pairs through emulsion PCR, enabling orthogonal receptor-ligand validation and production of specific effector molecules.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If growth assays are used for selection, then selection pressure is applied, but signaling is confounded with fitness effects caused by the ligand or receptor
Solution Approach 1:
The patent extracts the selection readout from growth-based assays and relocates it to a growth-independent reporter system. A fluorescent reporter gene is integrated into the yeast genome under the control of a promoter responsive to GPCR signaling, allowing selection based on fluorescent signal rather than growth rate. This separates the selection pressure from confounding fitness effects, as cells are selected based on their ability to produce fluorescent signal in response to ligand binding, not on their growth rate which may be affected by the ligand or receptor itself.
2Measurement precision
If extensive screening is employed to identify specific compounds, then orthogonality can be validated, but the process is painstaking and time-consuming
Solution Approach 1:
The patent changes the measurement parameter from growth rate to fluorescent signal intensity, enabling rapid quantification of receptor-ligand interactions. By using flow cytometry or plate reader-based fluorescent assays, thousands of compounds can be screened in parallel against multiple DREADD variants simultaneously. The fluorescent reporter provides a quantitative readout that can be measured quickly without waiting for cell growth, reducing screening time from days to hours while maintaining high precision in orthogonality validation through dose-response curves and specificity assays.
3Productivity
If selection is based on growth, then selection pressure is applied, but cheaters may arise that yield improved growth due to mutations outside the target gene
Solution Approach 1:
The patent introduces a fluorescent reporter gene as an intermediary between the GPCR signaling pathway and the selection readout. The reporter is placed under the control of a promoter that is activated specifically by GPCR signaling (e.g., a heterologous promoter that responds to the G-protein coupled receptor pathway). This intermediary ensures that only cells with functional GPCR-ligand interactions will produce the fluorescent signal, preventing cheater mutants that arise from general growth advantages. The fluorescent signal acts as a faithful mediator that reports specifically on the target pathway activity rather than overall cellular fitness.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the efficient selection and validation of orthogonal receptor-ligand pairs, facilitating the production of specific effector molecules and allowing for the modulation of neural interactions without affecting other neural receptors, thereby enhancing the complexity of neural probes.
Implementation Method 1
Emulsification of libraries of organisms with primers that can amplify the partner gene led to the selective amplification of those partner genes that were best able to produce the thermostable polymerase during thermal cycling of the emulsion
Data Source
AI summary
Disclosed herein are methods and platforms using Receptor Compartmentalized Partnered Replication (CPR), in which the partner gene is a receptor, signal transduction pathway, or metabolic pathway that leads to the production of an effector molecule for the receptor or signal transduction pathway. The signal transduction pathway or receptor is coupled to the production of a thermostable polymerase. Emulsification of libraries of organisms with primers that can amplify the partner gene led to the selective amplification of those partner genes that were best able to produce the thermostable polymerase during thermal cycling of the emulsion.